Changes
On June 30, 2022, 09:07:52 (SAST),
-
Added resource Vaccine types to Africa/global vaccination rollouts
f | 1 | { | f | 1 | { |
2 | "author": "Gemma Ritchie", | 2 | "author": "Gemma Ritchie", | ||
3 | "author_email": "[email protected]", | 3 | "author_email": "[email protected]", | ||
4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | 4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | ||
5 | "extras": [], | 5 | "extras": [], | ||
6 | "groups": [], | 6 | "groups": [], | ||
7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
8 | "isopen": true, | 8 | "isopen": true, | ||
9 | "license_id": "cc-by", | 9 | "license_id": "cc-by", | ||
10 | "license_title": "Creative Commons Attribution", | 10 | "license_title": "Creative Commons Attribution", | ||
11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | 11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | ||
12 | "maintainer": "Gemma Ritchie", | 12 | "maintainer": "Gemma Ritchie", | ||
13 | "maintainer_email": "[email protected]", | 13 | "maintainer_email": "[email protected]", | ||
14 | "metadata_created": "2022-06-30T06:48:12.490391", | 14 | "metadata_created": "2022-06-30T06:48:12.490391", | ||
n | 15 | "metadata_modified": "2022-06-30T06:48:12.490400", | n | 15 | "metadata_modified": "2022-06-30T07:07:52.725314", |
16 | "name": "africa-global-vaccination-rollouts", | 16 | "name": "africa-global-vaccination-rollouts", | ||
17 | "notes": "<p>This folder has three files:\r\n- A table of the types | 17 | "notes": "<p>This folder has three files:\r\n- A table of the types | ||
18 | of Covid-19 vaccines and their manufacturers which are fully approved | 18 | of Covid-19 vaccines and their manufacturers which are fully approved | ||
19 | or approved only for emergency use\r\n- A table of countries that have | 19 | or approved only for emergency use\r\n- A table of countries that have | ||
20 | approved the Covid-19 vaccines\r\n- A table of doses delivered to | 20 | approved the Covid-19 vaccines\r\n- A table of doses delivered to | ||
21 | countries\r\n</p>\r\n*This data was last updated on 30 June 2022.*", | 21 | countries\r\n</p>\r\n*This data was last updated on 30 June 2022.*", | ||
n | 22 | "num_resources": 0, | n | 22 | "num_resources": 1, |
23 | "num_tags": 5, | 23 | "num_tags": 5, | ||
24 | "organization": { | 24 | "organization": { | ||
25 | "approval_status": "approved", | 25 | "approval_status": "approved", | ||
26 | "created": "2022-06-29T10:06:22.005628", | 26 | "created": "2022-06-29T10:06:22.005628", | ||
27 | "description": "Media Hack Collective collect, analyse, and | 27 | "description": "Media Hack Collective collect, analyse, and | ||
28 | visualise data to tell engaging and effective stories. Media Hack | 28 | visualise data to tell engaging and effective stories. Media Hack | ||
29 | Collective are a partner organisation in the Africa Data Hub. Their | 29 | Collective are a partner organisation in the Africa Data Hub. Their | ||
30 | website can be found [here](https://mediahack.co.za/)", | 30 | website can be found [here](https://mediahack.co.za/)", | ||
31 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 31 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
32 | "image_url": "https://mediahack.co.za/_images/logo.png", | 32 | "image_url": "https://mediahack.co.za/_images/logo.png", | ||
33 | "is_organization": true, | 33 | "is_organization": true, | ||
34 | "name": "media-hack-collective", | 34 | "name": "media-hack-collective", | ||
35 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | 35 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | ||
36 | "state": "active", | 36 | "state": "active", | ||
37 | "title": "Media Hack Collective", | 37 | "title": "Media Hack Collective", | ||
38 | "type": "organization" | 38 | "type": "organization" | ||
39 | }, | 39 | }, | ||
40 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 40 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
41 | "private": false, | 41 | "private": false, | ||
42 | "relationships_as_object": [], | 42 | "relationships_as_object": [], | ||
43 | "relationships_as_subject": [], | 43 | "relationships_as_subject": [], | ||
t | 44 | "resources": [], | t | 44 | "resources": [ |
45 | { | ||||
46 | "cache_last_updated": null, | ||||
47 | "cache_url": null, | ||||
48 | "created": "2022-06-30T07:07:52.749707", | ||||
49 | "datastore_active": false, | ||||
50 | "description": "<p>This dataset contains descriptive information | ||||
51 | about vaccines that are in use in countries around the world or have | ||||
52 | been approved for use (emergency, limited, or full approval), along | ||||
53 | with information on who manufacturers the vaccine, type of vaccine, | ||||
54 | number of doses required etc. New vaccines will be added when they are | ||||
55 | either approved by a country, or a country starts to vaccinate with | ||||
56 | them. </p>. \r\n<br /> *Data as of 30 June 2022*. \r\n\r\n<br | ||||
57 | />##Description of variables\r\n<br />**ID:**ID number. \r\n\r\n<br /> | ||||
58 | **Vaccine_platform_acronymn:**Acronym for platform used to carry the | ||||
59 | vaccine. \r\n\r\n<br />**Vaccine_platform_description:** Description | ||||
60 | of platform used to carry the vaccine. \r\n\r\n<br | ||||
61 | />**Number_of_doses:** Number of doses of vaccine needed to be fully | ||||
62 | vaccinated. \r\n\r\n<br />**Dosing_schedule** Days when vaccines | ||||
63 | should be delivered. \r\n\r\n<br />**Route_of_administration:** How is | ||||
64 | vaccine administered. \r\n\r\n<br />**Type_of_vaccine:** Description | ||||
65 | of the type of vaccine. \r\n\r\n<br />**Names:** The name of the | ||||
66 | vaccine, this is sometimes more like a product code than a name eg | ||||
67 | BBIBP-CorV, or Ad26.COV2.S. Some vaccines appear to have more than one | ||||
68 | name. \r\n\r\n<br />**Common_name:** The most commonly used name of a | ||||
69 | vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||||
70 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||||
71 | \r\n\r\n<br />**storage:** Temperature at which vaccine has to be | ||||
72 | stored. \r\n\r\n<br />**Developers:** Name of company that developed | ||||
73 | the vaccine. \r\n\r\n<br />**Country_of_origin:** Country or countries | ||||
74 | developer company is based. \r\n\r\n<br />**Phase:** Phase of clinical | ||||
75 | trial. \r\n\r\n<br />**Covax:** Yes or No variable. Is the vaccine | ||||
76 | part of the Covax initiative? \r\n\r\n<br | ||||
77 | />**WHO_emergency_use_listing:** Description of where the vaccine is | ||||
78 | in the WHO\u2019s emergency listing process. \r\n\r\n<br | ||||
79 | />**Data_of_who_recommendation:** Date on which WHO emergency use | ||||
80 | listing was approved\r\n \r\n\r\n<br />**efficacy_1:** Percentage. | ||||
81 | What is the vaccine\u2019s efficacy on \u201cwild\u201d SARS-Cov-2 | ||||
82 | virus from Phase 3 or 4 clinical trials? \r\n\r\n<br /> | ||||
83 | **efficacy_RSA:** Percentage. What is the efficacy of the virus when | ||||
84 | tested against the B.1.315 variant, which is dominant in South Africa? | ||||
85 | \r\n\r\n<br />**date_of_test_results_1:** Date the efficacy_1 results | ||||
86 | were published. \r\n\r\n<br />**Results_published:** No means results | ||||
87 | have not been published in peer-reviewed journal. Name of journal if | ||||
88 | results have been published. \r\n\r\n<br | ||||
89 | />**date_results-published:**Date when results were published in | ||||
90 | peer-reviewed journal\r\n\r\n<br /> | ||||
91 | j6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n\r\n\r\n", | ||||
92 | "format": "", | ||||
93 | "hash": "", | ||||
94 | "id": "f2f33f2f-2be1-4f65-9751-b2cbbd5446a4", | ||||
95 | "last_modified": null, | ||||
96 | "mimetype": null, | ||||
97 | "mimetype_inner": null, | ||||
98 | "name": "Vaccine types", | ||||
99 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||||
100 | "position": 0, | ||||
101 | "resource_type": null, | ||||
102 | "revision_id": "2d4f4966-9590-4579-b01a-3717393ef7f8", | ||||
103 | "size": null, | ||||
104 | "state": "active", | ||||
105 | "url": | ||||
106 | nLY7XDGB5PAr1oErpwp1PyG_bb9nEFTPql/pubhtml?gid=883047759&single=true", | ||||
107 | "url_type": null | ||||
108 | } | ||||
109 | ], | ||||
45 | "revision_id": "79c31d0c-fc4c-4ca7-a519-555f6cfcdc3f", | 110 | "revision_id": "79c31d0c-fc4c-4ca7-a519-555f6cfcdc3f", | ||
46 | "state": "draft", | 111 | "state": "draft", | ||
47 | "tags": [ | 112 | "tags": [ | ||
48 | { | 113 | { | ||
49 | "display_name": "Africa", | 114 | "display_name": "Africa", | ||
50 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | 115 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | ||
51 | "name": "Africa", | 116 | "name": "Africa", | ||
52 | "state": "active", | 117 | "state": "active", | ||
53 | "vocabulary_id": null | 118 | "vocabulary_id": null | ||
54 | }, | 119 | }, | ||
55 | { | 120 | { | ||
56 | "display_name": "Covax", | 121 | "display_name": "Covax", | ||
57 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | 122 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | ||
58 | "name": "Covax", | 123 | "name": "Covax", | ||
59 | "state": "active", | 124 | "state": "active", | ||
60 | "vocabulary_id": null | 125 | "vocabulary_id": null | ||
61 | }, | 126 | }, | ||
62 | { | 127 | { | ||
63 | "display_name": "Covid-19", | 128 | "display_name": "Covid-19", | ||
64 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | 129 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | ||
65 | "name": "Covid-19", | 130 | "name": "Covid-19", | ||
66 | "state": "active", | 131 | "state": "active", | ||
67 | "vocabulary_id": null | 132 | "vocabulary_id": null | ||
68 | }, | 133 | }, | ||
69 | { | 134 | { | ||
70 | "display_name": "Covid-19 vaccines", | 135 | "display_name": "Covid-19 vaccines", | ||
71 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | 136 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | ||
72 | "name": "Covid-19 vaccines", | 137 | "name": "Covid-19 vaccines", | ||
73 | "state": "active", | 138 | "state": "active", | ||
74 | "vocabulary_id": null | 139 | "vocabulary_id": null | ||
75 | }, | 140 | }, | ||
76 | { | 141 | { | ||
77 | "display_name": "vaccines", | 142 | "display_name": "vaccines", | ||
78 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | 143 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | ||
79 | "name": "vaccines", | 144 | "name": "vaccines", | ||
80 | "state": "active", | 145 | "state": "active", | ||
81 | "vocabulary_id": null | 146 | "vocabulary_id": null | ||
82 | } | 147 | } | ||
83 | ], | 148 | ], | ||
84 | "title": "Africa/global vaccination rollouts", | 149 | "title": "Africa/global vaccination rollouts", | ||
85 | "type": "dataset", | 150 | "type": "dataset", | ||
86 | "url": "Multiple sources. See Methodology section", | 151 | "url": "Multiple sources. See Methodology section", | ||
87 | "version": "" | 152 | "version": "" | ||
88 | } | 153 | } |